Hai cercato la traduzione di infection da Finlandese a Tedesco

infection control
infektionskontrolle

treatment of adenovirus infection in immunocompromised patients
treatment of adenovirus infection in immunocompromised patients

treatment of diarrhoea associated with intestinal microsporidial infection
treatment of diarrhoea associated with intestinal microsporidial infection

a) cattle b) adjunctive therapy in acute respiratory infection
a) rinder b) zusatzbehandlung b e i akuten atemwegs- infektionen

infektioiden valvontapolitiikkaa (infection control policy) koskevan kyselyn (ks.
ein verbessertes verständnis der risikofaktoren, die an der entstehung und ausbreitung von antibiotika-resistenzen beteiligt sind, ist dringend notwendig.

mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of escherichia coli.
mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of escherichia coli.

note for guidance on the clinical development of medicinal products for the treatment of hiv infection.
note for guidance on the clinical development of medicinal products for the treatment of hiv infection.

active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents
j07bc01 active immunisation against hepatitis b virus infection caused by all known subtypes in children and adolescents

single- dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:
single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women:

prevention of invasive infections due to vancomycin resistant enterococci (vre) in colonised patients deemed at risk of infection
prevention of invasive infections due to vancomycin resistant enterococci (vre) in colonised patients deemed

asiakirjan nimi points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi) note for guidance on the clinical development of medicinal products for the treatment of hiv infection.
titel des dokuments points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi) note for guidance on the clinical development of medicinal products for the treatment of hiv infection.

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/or intramuscular use (cpmp/bpwg/574/99)